MentionFox
Home › funding signals › Zero Point Five Therapeutics, Inc.
Form D · on the record

Zero Point Five Therapeutics — $4.30M Form D filing, April 2025

Before you sell to, join or invest in Zero Point Five Therapeutics, Inc.

MentionFox check on Zero Point Five Therapeutics, Inc.: only 1 source on file so far (checked 4 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/zero-point-five-therapeutics-inc-form-d-25000001

Check Zero Point Five Therapeutics, Inc. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Zero Point Five Therapeutics, Inc.?

Based on the record MentionFox holds for this company. No flag is not a clearance.

Zero Point Five Therapeutics, Inc. filed a Form D with the Securities and Exchange Commission on 2025-04-17.

Zero Point Five Therapeutics, Inc. filed a Form D notice of an exempt securities offering with the SEC on April 17, 2025. The filing reports $4.30M sold. Its industry group is Biotechnology. It names Joseph Amprey III (Executive Officer, Director), Ben Auspitz (Director), Jodi Jahic (Director) (SEC Form D, April 17, 2025).

5 more Biotechnology raises in Maryland within 90 days ↓

Is this your company?

Key facts

Run the free check on Zero Point Five Therapeutics, Inc. →

Sell to companies like Zero Point Five Therapeutics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Zero Point Five Therapeutics, Inc.

New Form D on file · 2025-04-17 · the record

$4.30M
raise on the record
D
filing
10
investors in
MARYLAND
based
Open the record →

What the record says

FilingForm D
Filed2025-04-17
Industry groupBiotechnology
Entity typeCorporation
Incorporated inDISTRICT OF COLUMBIA
BasedBALTIMORE, MARYLAND
CIK1985295
Accession0002054934-25-000002

Pitching, partnering or investing alongside them? See who really runs and owns Zero Point Five Therapeutics, Inc.

Watch Zero Point Five Therapeutics, Inc.: email me the next time it files something

Free to see. No signup.

Keep reading

More on the people and the money behind Zero Point Five Therapeutics, Inc., from the filings we hold.

More raises like this

Biotechnology raises by companies based in Maryland, filed within 90 days of this one, largest first.

What do you want to do with Zero Point Five Therapeutics, Inc.?

Get the full cited report on Zero Point Five Therapeutics, Inc.

What the filing shows about Zero Point Five Therapeutics, Inc.

  • 10 investors had already put money in when it filed.
  • The filing names 3 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Zero Point Five Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Who the filing names, and in what role

The filing gives Zero Point Five Therapeutics, Inc.'s address as 915 S. Eaton Street, Baltimore, MD 21224.

Keep digging

Who else raised the same week in biotechnology

What the filing says

  • Offered: $5,333,250. Sold: $4,299,420. Left to sell: $1,033,830. (filing)
  • Investors: 10 had already invested. (filing)
  • Date of first sale: April 2, 2025. (filing)
  • Types of securities: Equity. (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters. (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on Zero Point Five Therapeutics, Inc. See pricing

Is Zero Point Five Therapeutics, Inc. a real, registered company?

Zero Point Five Therapeutics, Inc. is a registered filer with the SEC (CIK 1985295) and has filed since 2023-07-12. 2 filings are on record, the latest on 2025-04-17.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs Zero Point Five Therapeutics, Inc.?

Zero Point Five Therapeutics, Inc.'s Form D of 2025-04-17 names Joseph Amprey III, Ben Auspitz and Jodi Jahic as its officers, directors or promoters.

How much has Zero Point Five Therapeutics, Inc. raised?

Its new offerings report $11.52M sold across 2 offerings, as its own filings state.

Filing history · 2 filings on this registrant
Form D · 2023-07-12 · $7.22MForm D · 2025-04-17 · $4.30M · this page 2023-07-12 2025-04-17

Each marker is one filing. The larger marker is the filing this page is about.

Biotechnology · by week

Trailing twelve months. 766 filings in Biotechnology, totalled by week.

Want the whole picture on Zero Point Five Therapeutics, Inc.?

What the filing shows about Zero Point Five Therapeutics, Inc.

  • 10 investors had already put money in when it filed.
  • The filing names 3 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Zero Point Five Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Zero Point Five Therapeutics, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind Zero Point Five Therapeutics, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.

Sourced from the filing index on sec.gov.

RSS

Tools for this story

Each opens in a new tab, filled in for Zero Point Five Therapeutics, Inc.. With no account yet, you sign up free and land on the result.

Share this page

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

Zero Point Five Therapeutics, Inc.: Raised $4.30M, Form D filed 2025-04-17
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/zero-point-five-therapeutics-inc-form-d-25000001
Last updated 2026-11-04
Primary record: SEC filing 1 · SEC filing 2
Zero Point Five Therapeutics raised $4.30M — SEC Form D filing, April 2025. MentionFox, 2026-11-04. https://mentionfox.com/funding/zero-point-five-therapeutics-inc-form-d-25000001